BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Revolutions Medical Corporation Files an International Patent Application Under PCT for Its New Pre-Filled Auto-Retractable Vacuum Safety Syringe Technology


5/3/2012 9:45:05 AM

CHARLESTON, S.C., May 3, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) designating all PCT member countries. The patent application is directed to novel proprietary designs for pre-filled and non-pre filled vacuum based retractable syringes. The U.S. provisional patent was filed May 2, 2011 on Revolutions Medical's new pre-filled technology. The new designs improve safety and ease of use, while reducing the cost and complexity of manufacture. The international PCT patent application will strengthen the Company's overall patent coverage related to vacuum safety syringe technology and will allow the Company to address a growing market segment currently experiencing significant attention by pharmaceutical companies.

Read at GlobeNewswire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->